5-HT(3) antagonist therapy of bulimia nervosa: a peripherally active agent for a central nervous system eating disorder?
Hasler
W L
WL
D000328:Adult; D002032:Bulimia / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D017294:Ondansetron / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D012702:Serotonin Antagonists; D017294:Ondansetron